<?xml version="1.0" encoding="UTF-8"?>
<ref id="B39-marinedrugs-17-00374" class="ref">
 <label class="label">39.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Bays</surname>
    <given-names class="given-names">H.E.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Ballantyne</surname>
    <given-names class="given-names">C.M.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Braeckman</surname>
    <given-names class="given-names">R.A.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Stirtan</surname>
    <given-names class="given-names">W.G.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Soni</surname>
    <given-names class="given-names">P.N.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">Icosapent ethyl, a pure ethyl ester of eicosapentaenoic acid: Effects on circulating markers of inflammation from the MARINE and ANCHOR studies</article-title>
  <source class="source">Am. J. Cardiovasc. Drugs.</source>
  <year class="year">2013</year>
  <volume class="volume">13</volume>
  <fpage class="fpage">37</fpage>
  <lpage class="lpage">46</lpage>
  <pub-id pub-id-type="doi" class="pub-id">10.1007/s40256-012-0002-3</pub-id>
  <pub-id pub-id-type="pmid" class="pub-id">23325450</pub-id>
 </element-citation>
</ref>
